Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2017 1
2018 1
2020 3
2021 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Effect of IBD medications on COVID-19 outcomes: results from an international registry.
Ungaro RC, Brenner EJ, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD. Ungaro RC, et al. Among authors: kissous hunt m. Gut. 2021 Apr;70(4):725-732. doi: 10.1136/gutjnl-2020-322539. Epub 2020 Oct 20. Gut. 2021. PMID: 33082265 Free PMC article.
The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis.
Kaplan GG, Underwood FE, Coward S, Agrawal M, Ungaro RC, Brenner EJ, Gearry RB, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Steinwurz F, Zhang X, Kappelman MD, Colombel JF. Kaplan GG, et al. Among authors: kissous hunt m. Inflamm Bowel Dis. 2022 Nov 2;28(11):1687-1695. doi: 10.1093/ibd/izab339. Inflamm Bowel Dis. 2022. PMID: 35032167 Free PMC article.
COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States.
Agrawal M, Brenner EJ, Yan Mak JW, Zhang X, Kaplan GG, Ng SC, Reinisch W, Steinwurz F, Lewis JD, Kissous-Hunt M, Modesto I, Ungaro RC, Colombel JF, Kappelman MD. Agrawal M, et al. Among authors: kissous hunt m. Clin Gastroenterol Hepatol. 2021 Oct;19(10):2210-2213.e3. doi: 10.1016/j.cgh.2021.05.060. Epub 2021 Jun 2. Clin Gastroenterol Hepatol. 2021. PMID: 34089848 Free PMC article.
Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry.
Agrawal M, Brenner EJ, Zhang X, Colombel JF, Kappelman MD, Ungaro RC; SECURE-IBD Advisory Committee including; Gearry RB, Kalpan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Ruemmele FM, Steinwurz F, Underwood FE. Agrawal M, et al. Among authors: kissous hunt m. J Crohns Colitis. 2021 May 4;15(5):860-863. doi: 10.1093/ecco-jcc/jjaa243. J Crohns Colitis. 2021. PMID: 33232456 Free PMC article.
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry.
Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Ruemmele FM, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD. Brenner EJ, et al. Among authors: kissous hunt m. Gastroenterology. 2020 Aug;159(2):481-491.e3. doi: 10.1053/j.gastro.2020.05.032. Epub 2020 May 18. Gastroenterology. 2020. PMID: 32425234 Free PMC article.